Market Overview:
The global POC molecular diagnostics market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The increasing demand for rapid and accurate diagnostic tests, rising prevalence of infectious diseases, growing number of cancer cases, and technological advancements are some of the major factors driving the growth of this market. Based on type, the global POC molecular diagnostics market is segmented into infectious diseases, oncology, hematology and endocrinology. Infectious diseases accounted for the largest share in 2017 and this segment is expected to grow at a CAGR of 11% during the forecast period from 2018 to 2030. Oncology is projected to be the fastest-growing type segment during the forecast period from 2018 to 2030. This growth can be attributed to increasing incidence rates of cancer across all regions globally coupled with rising awareness about early diagnosis and treatment options for cancer patients. Based on application, hospitals and clinics accounted for majority share in 2017 followed by research institutes; however research institutes are projected as fastest growing application segments with CAGR over 12%. Diagnostic laboratories held third largest share in terms revenue generated through sales owing mainly due high adoption rate among developed countries such as UAS.
Product Definition:
POC molecular diagnostics is a term used to describe the use of molecular techniques for the diagnosis of diseases in patients at or near the point-of-care. The importance of POC molecular diagnostics is that it allows for rapid and accurate diagnosis of diseases, which can lead to improved patient outcomes.
Infectious Diseases:
Infectious diseases are those which are caused by pathogens, bacteria, viruses or fungi. These pathogens live in the natural environment as well as in human and animal bodies. Some of the common infectious diseases include chickenpox, measles, mumps, influenza (flu), hepatitis A & B and rubella. The major aim of all these infections is to cause disease; for example chickenpox infects the body to produce Chicken Pox virus while flu infects the body to produce Flu virus.
Oncology:
Oncology is the study of cancer, a disease of cells caused by abnormal growth. The oncology market is expected to witness lucrative growth over the forecast period owing to increasing prevalence and incidence rates coupled with rising awareness about early diagnosis. Furthermore, technological advancements in molecular diagnostics are also expected to fuel market growth during the forecast period.
The global oncology.
Application Insights:
The hospital and clinic segment dominated the global POC molecular diagnostics market in 2017. This can be attributed to factors such as an increase in the prevalence of chronic diseases, growing investments by governments for the development of diagnostic centers, and rising awareness among consumers regarding access to advanced healthcare services.
For instance, according to a study published by WHO in 2018, it was estimated that around 1 billion people worldwide are suffering from some form of cancer. Furthermore, another study states that about 8 million people die due to cancer every year globally while around 14 million individuals are diagnosed with this disease each year globally. These statistics indicate a significant rise in demand for molecular diagnostic tests over the forecast period which is expected to drive growth during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to factors such as favorable reimbursement policies, increasing prevalence of infectious diseases and rising adoption of point-of-care molecular diagnostics by healthcare professionals for early diagnosis. Moreover, the presence of key players in this region is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving healthcare infrastructure and growing demand for cost-effective diagnostic tests that are portable and can be performed at remote sites without any supervision or assistance from a physician. Furthermore, an increase in government initiatives aimed at creating awareness regarding POC molecular diagnostics will also boost regional growth over the next eight years (from 2018 to 2030).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in molecular diagnostics
- Growing number of private and public sector initiatives for precision medicine
- Proliferation of genomics research
Scope Of The Report
Report Attributes
Report Details
Report Title
POC Molecular Diagnostics Market Research Report
By Type
Infectious Diseases, Oncology, Hematology and Endocrinology
By Application
Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Others
By Companies
Abbott, bioMerieux, Danaher, BD, Certest Biotec, F. Hoffmann-La Roche, NeoGenomics, Bionano Genomics, ExcitePCR, Micronics, Nimagen, Novigenix, Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
193
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global POC Molecular Diagnostics Market Report Segments:
The global POC Molecular Diagnostics market is segmented on the basis of:
Types
Infectious Diseases, Oncology, Hematology and Endocrinology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- bioMerieux
- Danaher
- BD
- Certest Biotec
- F. Hoffmann-La Roche
- NeoGenomics
- Bionano Genomics
- ExcitePCR
- Micronics
- Nimagen
- Novigenix
- Merck
Highlights of The POC Molecular Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infectious Diseases
- Oncology
- Hematology and Endocrinology
- By Application:
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the POC Molecular Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
POC Molecular Diagnostics is a molecular diagnostics company that provides rapid, affordable and accurate tests for the detection of rare diseases. POC Molecular Diagnostics' tests are based on cutting-edge technologies that allow for the detection of small amounts of genetic material. This information can then be used to help diagnose rare diseases and provide patients with more accurate treatment options.
Some of the key players operating in the poc molecular diagnostics market are Abbott, bioMerieux, Danaher, BD, Certest Biotec, F. Hoffmann-La Roche, NeoGenomics, Bionano Genomics, ExcitePCR, Micronics, Nimagen, Novigenix, Merck.
The poc molecular diagnostics market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 POC Molecular Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 POC Molecular Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 POC Molecular Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the POC Molecular Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global POC Molecular Diagnostics Market Size & Forecast, 2020-2028
4.5.1 POC Molecular Diagnostics Market Size and Y-o-Y Growth
4.5.2 POC Molecular Diagnostics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Infectious Diseases
5.2.2 Oncology
5.2.3 Hematology and Endocrinology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals and Clinics
6.2.2 Research Institutes
6.2.3 Diagnostic Laboratories
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global POC Molecular Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 POC Molecular Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Infectious Diseases
9.6.2 Oncology
9.6.3 Hematology and Endocrinology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals and Clinics
9.10.2 Research Institutes
9.10.3 Diagnostic Laboratories
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Infectious Diseases
10.6.2 Oncology
10.6.3 Hematology and Endocrinology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals and Clinics
10.10.2 Research Institutes
10.10.3 Diagnostic Laboratories
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Infectious Diseases
11.6.2 Oncology
11.6.3 Hematology and Endocrinology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals and Clinics
11.10.2 Research Institutes
11.10.3 Diagnostic Laboratories
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Infectious Diseases
12.6.2 Oncology
12.6.3 Hematology and Endocrinology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals and Clinics
12.10.2 Research Institutes
12.10.3 Diagnostic Laboratories
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Infectious Diseases
13.6.2 Oncology
13.6.3 Hematology and Endocrinology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals and Clinics
13.10.2 Research Institutes
13.10.3 Diagnostic Laboratories
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 POC Molecular Diagnostics Market: Competitive Dashboard
14.2 Global POC Molecular Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 bioMerieux
14.3.3 Danaher
14.3.4 BD
14.3.5 Certest Biotec
14.3.6 F. Hoffmann-La Roche
14.3.7 NeoGenomics
14.3.8 Bionano Genomics
14.3.9 ExcitePCR
14.3.10 Micronics
14.3.11 Nimagen
14.3.12 Novigenix
14.3.13 Merck
